mPLUS Corp. (KOSDAQ:259630)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,200.00
-40.00 (-0.43%)
At close: Aug 8, 2025, 3:30 PM KST

Achilles Therapeutics Revenue

mPLUS had revenue of 23.21B KRW in the quarter ending March 31, 2025, with 7.62% growth. This brings the company's revenue in the last twelve months to 130.39B, down -62.63% year-over-year. In the year 2024, mPLUS had annual revenue of 128.74B, down -62.14%.

Revenue (ttm)
130.39B
Revenue Growth
-62.63%
P/S Ratio
0.83
Revenue / Employee
360.19M
Employees
362
Market Cap
108.77B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024128.74B-211.31B-62.14%
Dec 31, 2023340.05B223.44B191.61%
Dec 31, 2022116.61B40.13B52.47%
Dec 31, 202176.48B-82.06B-51.76%
Dec 31, 2020158.54B54.20B51.94%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition